Literature DB >> 12801625

Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment.

Vasilios G Athyros, Athanasios A Papageorgiou, Athanasios N Symeonidis, Moses Elisaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12801625     DOI： 10.1016/s0021-9150(03)00128-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.

Authors:  Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

Review 2.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.